Final results of DESTINY-CRC01 investigating trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancerTakayuki Yoshino, Yasuyuki Okuda, Kapil Saxena et al.|Nature Communications|2023Cited by 159
Clinical outcome of 42 patients treated with 81 immediately loaded zygomatic implants: a 12- to 42-month retrospective study.Rubén Davó, Jose Regolf, Juliana Rojas et al.|PubMed|2010Cited by 73